Copyright
©The Author(s) 2025.
World J Hepatol. Sep 27, 2025; 17(9): 108144
Published online Sep 27, 2025. doi: 10.4254/wjh.v17.i9.108144
Published online Sep 27, 2025. doi: 10.4254/wjh.v17.i9.108144
Figure 1 Mechanisms associated with fibrosis regression in metabolic dysfunction-associated steatohepatitis after bariatric surgery and procedures.
ESG: Endoscopic sleeve gastroplasty; MASH: Metabolic dysfunction-associated steatohepatitis; GLP-1: Glucagon-like peptide-1; PYY: Peptide tyrosine tyrosine.
- Citation: Sierra L, Chatterjee A, Prado R, Khurana A, Patel R, Firkins S, Simons-Linares R. Impact of metabolic endoscopy on fibrosis regression in steatotic liver disease. World J Hepatol 2025; 17(9): 108144
- URL: https://www.wjgnet.com/1948-5182/full/v17/i9/108144.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i9.108144